Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors

Jiaming Shen, Xia Wang, Guangde Yang, Li Li, Juan Fu, Wei Xu, Qingqiao Zhang, Xiucheng PanJournal of Hepatocellular Carcinoma 2024 · DOI

Abstract

Liver injury adverse events are common in HBV-related HCC patients treated with TACE-TKIs-ICIs. Patients who developed liver injury had a poor prognosis. For HBV-related HCC patients, effective prophylactic antiviral therapy and regular liver function testing are required before and during this triple therapy.
BibTeX
@article{shen2024liver,
  author = {Jiaming Shen and Xia Wang and Guangde Yang and Li Li and Juan Fu and Wei Xu and Qingqiao Zhang and Xiucheng Pan},
  title = {{Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors}},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2024},
  doi = {10.2147/jhc.s431191},
}

Loading related content...

Figure